Collaboration with Spiber Featured in Nikkei Sangyo Shimbun
Our collaboration with Spiber Inc. was featured in the digital edition of Nikkei Sangyo Shimbun on May 20, 2022.
The article introduces the results of the joint research that began in 2020, along with comments from Epistra’s researchers. The article highlights how Spiber is leveraging AI technology in its research, and a researcher from Spiber commented that by using Epistra’s experiment optimization system, “results that used to take two years can now be obtained in just a few weeks.”
In this joint research, Epistra’s proprietary solution “Epistra Accelerate” is being used to drive the automation and optimization of experiments.
Related Articles
Won Grand Prix in the 7th IP BASE AWARD Startup Category Hosted by the Japan Patent Office
On March 3, 2026, Epistra Inc. won the Grand Prix in the startup category at the '7th IP BASE AWARD' ceremony hosted by the Japan Patent Office.
Jikkenigaku Special Issue 'AI and Data-Driven Drug Discovery Research' Published — CTO Tsuzuki Authors Chapter on AI-Driven Drug Target Discovery
In 'Jikkenigaku Special Issue: AI and Data-Driven Drug Discovery Research' published by Yodosha, our CTO Taku Tsuzuki authored a chapter on AI-driven knowledge mining for drug target discovery.
Speaking Engagement: Delivered Keynote at the 10th Cell Manufacturing Kotozukuri Symposium
On March 4, 2026, CEO Yosuke Ozawa delivered a keynote speech on optimizing cell manufacturing processes using AI and robotics at the '10th Cell Manufacturing Kotozukuri Symposium' hosted by Osaka University.